| Product Code: ETC6522001 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for bortezomib import shipments in Brunei saw a significant decline with a negative CAGR of -35.83% from 2020 to 2024. In 2024, the top countries exporting to Brunei were South Korea, Australia, Malaysia, Thailand, and Canada, indicating a diverse source of imports. Despite the high concentration with a high Herfindahl-Hirschman Index (HHI) in 2024, the growth rate plummeted by -85.58% from 2023 to 2024, reflecting a challenging market environment. Monitoring shifts in exporting countries and addressing factors contributing to the negative growth rate will be crucial for stakeholders in the bortezomib market in Brunei.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Bortezomib Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Bortezomib Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Bortezomib Market - Industry Life Cycle |
3.4 Brunei Bortezomib Market - Porter's Five Forces |
3.5 Brunei Bortezomib Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Brunei Bortezomib Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Brunei Bortezomib Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Brunei Bortezomib Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Brunei Bortezomib Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Brunei Bortezomib Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Bortezomib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Brunei |
4.2.2 Growing awareness about the benefits of bortezomib in cancer treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost of bortezomib treatment |
4.3.2 Limited availability of skilled healthcare professionals for administering bortezomib |
4.3.3 Stringent regulations and approval processes for importing and using bortezomib in Brunei |
5 Brunei Bortezomib Market Trends |
6 Brunei Bortezomib Market, By Types |
6.1 Brunei Bortezomib Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Brunei Bortezomib Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Brunei Bortezomib Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 Brunei Bortezomib Market Revenues & Volume, By 3.5mg, 2021- 2031F |
6.1.5 Brunei Bortezomib Market Revenues & Volume, By 5mg, 2021- 2031F |
6.1.6 Brunei Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brunei Bortezomib Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Brunei Bortezomib Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.3 Brunei Bortezomib Market Revenues & Volume, By Mantle Cell Lymphoma, 2021- 2031F |
6.2.4 Brunei Bortezomib Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
6.2.5 Brunei Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Brunei Bortezomib Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Brunei Bortezomib Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.3 Brunei Bortezomib Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 Brunei Bortezomib Market Revenues & Volume, By Powder, 2021- 2031F |
6.3.5 Brunei Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Brunei Bortezomib Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Brunei Bortezomib Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Brunei Bortezomib Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.4 Brunei Bortezomib Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.5 Brunei Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Brunei Bortezomib Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Brunei Bortezomib Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Brunei Bortezomib Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Brunei Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Brunei Bortezomib Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Brunei Bortezomib Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Brunei Bortezomib Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Brunei Bortezomib Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Brunei Bortezomib Market Import-Export Trade Statistics |
7.1 Brunei Bortezomib Market Export to Major Countries |
7.2 Brunei Bortezomib Market Imports from Major Countries |
8 Brunei Bortezomib Market Key Performance Indicators |
8.1 Patient survival rates after bortezomib treatment |
8.2 Number of healthcare facilities offering bortezomib treatment |
8.3 Rate of adoption of bortezomib in different types of cancers in Brunei |
9 Brunei Bortezomib Market - Opportunity Assessment |
9.1 Brunei Bortezomib Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Brunei Bortezomib Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Brunei Bortezomib Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Brunei Bortezomib Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Brunei Bortezomib Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Brunei Bortezomib Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Bortezomib Market - Competitive Landscape |
10.1 Brunei Bortezomib Market Revenue Share, By Companies, 2024 |
10.2 Brunei Bortezomib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here